Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Paul W A, Janssen"'
Autor:
Laura M. Willemsen, Eline A. Vlot, Paul W. A. Janssen, Claire D. Visser, Kai Zheng, Johannes C. Kelder, Peter G. Noordzij, Erik‐Jan van den Dool, Patrick Klein, Christian M. Hackeng, Jurrien M. ten Berg
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 8, Pp n/a-n/a (2021)
Abstract Background Aspirin is important for preventing thrombotic events but also increases bleeding complications. Minimizing bleeding while preventing thrombotic events remains challenging in patients undergoing coronary artery bypass grafting (CA
Externí odkaz:
https://doaj.org/article/44e61c504d7449bbb67208104edc6fe6
Autor:
Thomas O. Bergmeijer, Mathijs van Oevelen, Paul W. A. Janssen, Thea C. Godschalk, Robert A. Lichtveld, Johannes C. Kelder, Michiel Voskuil, Arend Mosterd, Gilles Montalescot, Jurriën M. ten Berg
Publikováno v:
TH Open, Vol 02, Iss 04, Pp e357-e368 (2018)
Abstract Objectives The objective of this registry was to study the safety of prehospital initiation of ticagrelor compared with clopidogrel. Background Ticagrelor has replaced clopidogrel in many hospitals as the routinely used antiplatelet drug
Externí odkaz:
https://doaj.org/article/401a87929a5842ebbf3407cb620d1790
Autor:
Daniel M F, Claassens, Gerrit J A, Vos, Thomas O, Bergmeijer, Renicus S, Hermanides, Arnoud W J, van 't Hof, Pim, van der Harst, Emanuele, Barbato, Carmine, Morisco, Richard M, Tjon Joe Gin, Folkert W, Asselbergs, Arend, Mosterd, Jean-Paul R, Herrman, Willem J M, Dewilde, Paul W A, Janssen, Johannes C, Kelder, Maarten J, Postma, Anthonius, de Boer, Cornelis, Boersma, Vera H M, Deneer, Jurriën M, Ten Berg
Publikováno v:
The New England journal of medicine. 381(17)
It is unknown whether patients undergoing primary percutaneous coronary intervention (PCI) benefit from genotype-guided selection of oral P2YWe conducted a randomized, open-label, assessor-blinded trial in which patients undergoing primary PCI with s
Autor:
Paul W A, Janssen, Thomas O, Bergmeijer, Gert-Jan A, Vos, Johannes C, Kelder, Khalid, Qaderdan, Thea C, Godschalk, Nicoline J, Breet, Vera H M, Deneer, Christian M, Hackeng, Jurriën M, Ten Berg
Publikováno v:
European journal of clinical pharmacology. 75(9)
The POPular Risk Score was developed for the selective intensification of P2YIn a single-center prospective cohort study, patients with a high risk score were treated with prasugrel and patients with a low risk score with clopidogrel. The risk score-
Autor:
Willem J M, Dewilde, Paul W A, Janssen, Freek W A, Verheugt, Robert F, Storey, Tom, Adriaenssens, Morten L, Hansen, Morten, Lamberts, Jurriën M, ten Berg
Publikováno v:
Journal of the American College of Cardiology. 65(5)
Triple therapy for atrial fibrillation and percutaneous coronary intervention: a contemporary review
Autor:
Willem J M, Dewilde, Paul W A, Janssen, Freek W A, Verheugt, Robert F, Storey, Tom, Adriaenssens, Morten L, Hansen, Morten, Lamberts, Jurriën M, Ten Berg
Publikováno v:
Journal of the American College of Cardiology. 64(12)
Chronic oral anticoagulant therapy is recommended (class I) in patients with mechanical heart valves and in patients with atrial fibrillation with a CHA2DS2-VASc (Congestive heart failure, Hypertension, Age ≥75 years, Diabetes mellitus, prior Strok
Autor:
Dewilde WJ, Janssen PW; Dr. Paul W. A. Janssen, Cardiology, St. Antonius Hospital, Koekoekslaan 1, Nieuwegein Utrecht 3430, The Netherlands, Tel.: +31 088 3209679, Fax: +31 084 0033422, E-mail: p.janssen@antoniusziekenhuis.nl., Bergmeijer TO, Kelder JC, Hackeng CM, ten Berg JM
Publikováno v:
Thrombosis and haemostasis [Thromb Haemost] 2015 Oct; Vol. 114 (4), pp. 708-16. Date of Electronic Publication: 2015 Jul 16.